Association of interleukin 22 polymorphisms with gastric cancer risk
- 255 Downloads
Interleukin (IL)-22 has been implicated in inflammation and tumorigenesis. To date, no studies have investigated the role of IL-22 polymorphism in the carcinogenesis of gastric cancer (GC). In this study, we aimed to investigate the association of IL-22 polymorphisms with the risk of GC in a Chinese population. One hundred eight GC patients and 110 healthy controls were included in the study. IL-22 rs1179251, rs2227485, and rs2227473 polymorphisms were determined by PCR amplification and DNA sequencing. Haplotypes were constructed, and a possible association of these haplotypes with GC was assessed. The distribution of IL-22 rs1179251 polymorphism with clinical parameters was also analyzed. The IL-22 rs1179251 polymorphism was significantly associated with an increased risk of GC (p < 0.05). Stratified analysis revealed that rs1179251 was associated with advanced stages, lymph node metastases, and distant metastases of GC (p < 0.05). No associations were found between rs2227485 and rs2227473 and the risk of GC (p > 0.05). Three possible haplotypes (Crs1179251-Crs2227485-Grs2227485, Crs1179251-Trs2227485-Grs2227485, and Grs1179251-Trs2227485-Ars2227485) were identified, but no associations were found between these and the risk of GC (p > 0.05). In summary, our study demonstrates that the rs1179251 polymorphism of IL-22 was associated with an increased risk of GC and may influence the progression of GC. Future larger studies with other ethnic populations are required to confirm these findings.
KeywordsInterleukin-22 Gastric cancer Polymorphism
This work was supported by grants from the National Natural Scientific Foundation of China (81260083; 31360221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
- 14.Eun YG, Shin IH, Lee YC, Shin SY, Kim SK, et al. Interleukin 22 polymorphisms and papillary thyroid cancer. J Endocrinol Investig. 2013;36:584–7.Google Scholar
- 23.Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002;277:33676–82.CrossRefPubMedGoogle Scholar
- 31.Liu F, Pan X, Zhou L, Zhou J, Chen B, et al. Genetic polymorphisms and plasma levels of interleukin-22 contribute to the development of nonsmall cell lung cancer. DNA Cell Biol. 2014:33:705–14.Google Scholar